Add BrightSurf on Google Email

First significant genetic finding in severe PMS, or PMDD

A study has identified genetic variants associated with premenstrual dysphoric disorder (PMDD), a severe form of PMS. Women with specific variants in the estrogen receptor alpha gene were more likely to experience PMDD, suggesting hormonal factors play a key role in its development.

SourceElsevier·JournalBiological Psychiatry·DateOct 2, 2007

Noninvasive prenatal testing by analyzing mother's blood

Researchers have identified a pattern of fetal mRNAs detectable in pregnant women's blood, which could serve as a baseline for diagnosing genetic diseases. This detection method has the potential to replace invasive prenatal procedures, offering a new approach to monitoring fetal health.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 20, 2007

MIT IDs binocular vision gene

Researchers from the Picower Institute at MIT have identified the gene Ten_m3 as crucial for creating matched projections from both eyes in the brain. In mice with this gene knocked out, visual deficits persisted even when one eye was covered, but blocking the output of one eye restored vision.

SourceMassachusetts Institute of Technology·JournalPLOS Biology·DateSep 13, 2007

Gene predicts better outcome as cortex normalizes in teens with ADHD

A specific gene variant associated with attention deficit hyperactivity disorder (ADHD) may also predict better clinical outcomes and higher IQ in teens. The variant, called the 7-repeat version of the dopamine D4 receptor gene, is linked to thinner brain areas controlling attention but confers advantage only among youth with ADHD.

SourceNIH/National Institute of Mental Health·JournalArchives of General Psychiatry·DateAug 6, 2007

Research team enlightens the reasons for severe blindness

A research team has identified a genetic deficiency that causes severe blindness, specifically Leber Congenital Amaurosis (LCA). The discovery of the LCA5 gene and its protein lebercilin provides new opportunities for gene therapy, which could lead to the treatment of this disease in humans.

New databases put wings on search for bipolar risk genes

The Bipolar Disorder Phenome Database offers a comprehensive resource for researchers to identify genes linked to bipolar disorder, utilizing over 5,000 patients' clinical data and DNA samples. This database complements existing genetic data and enables researchers to correlate specific symptoms with genetic material.

SourceJohns Hopkins Medicine·JournalAmerican Journal of Psychiatry·DateJul 31, 2007

£2 million dwarfism study launched

An international team of researchers has been awarded £2 million to study the genetic causes of dwarfism and develop future treatments. The EuroGrow project aims to investigate the most common bone disorders that lead to short stature, with a focus on achondroplasia, pseudoachondroplasia, and spondyloepiphyseal dysplasia congenita.

Genetic roots of bipolar disorder revealed by first genome-wide study of illness

A genome-wide study reveals that variations in multiple genes contribute to the development of bipolar disorder. The researchers identified a promising target gene DGKH, which produces an enzyme involved in lithium's therapeutic effects. This discovery may lead to the development of new and more effective medications for bipolar disorder.

SourceNIH/National Institute of Mental Health·JournalMolecular Psychiatry·DateMay 8, 2007

How genetic malfunction causes a form of retardation

A study published in Neuron reveals that genetic mutations in SHP-2 lead to an imbalance in brain cell development, resulting in mental retardation. The researchers found that the mutation causes neurons to overgrow and inhibits glial cell formation, disrupting neural balance.

SourceCell Press·JournalNeuron·DateApr 18, 2007

New protein implicated in autism

A new protein, CADPS2, has been identified as a potential cause of autism. Research found that mice lacking this protein exhibited autistic-like characteristics, including impaired social interactions and hyperactivity.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 22, 2007

Origin of inherited pain disorder pinpointed

Researchers pinpointed paroxysmal extreme pain disorder (PEPD) to specific porelike sodium channels in peripheral nerve cells, highlighting the role of such channel disorders in inflammatory pain. Mutations in SCN9A gene were found to be responsible for at least two-thirds of PEPD cases.

SourceCell Press·JournalNeuron·DateDec 6, 2006

Gene therapy for hereditary lung disease advances

Researchers have successfully tested a gene therapy to combat alpha-1 antitrypsin deficiency, a common hereditary disorder that causes lung and liver disease. The treatment showed no adverse effects and introduced the corrective gene into patients' blood, with some evidence of protein production.

SourceUniversity of Florida·JournalHuman Gene Therapy·DateNov 21, 2006

How Rett Syndrome mutation targets the brain

Researchers identified a key mechanism behind Rett Syndrome by pinpointing the S421 site on the MeCP2 protein responsible for its normal function. This specificity explains why mutations affecting that site target brain development, leading to delays in motor skills and speech loss.

SourceCell Press·JournalNeuron·DateOct 18, 2006